135 related articles for article (PubMed ID: 38590014)
21. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
[TBL] [Abstract][Full Text] [Related]
22. BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms.
Gerami P; Chen A; Sharma N; Patel P; Hagstrom M; Kancherla P; Geraminejad T; Olivares S; Biswas A; Bosenberg M; Busam KJ; de La Fouchardière A; Duncan LM; Elder DE; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Mihic-Probst D; Parker DC; Scolyer RA; Shea CR; Zembowicz A; Yun SJ; Blokx WAM; Barnhill RL
Am J Surg Pathol; 2024 May; 48(5):538-545. PubMed ID: 38525831
[TBL] [Abstract][Full Text] [Related]
23. Superficial melanocytic neoplasms with pagetoid melanocytosis: a study of interobserver concordance and correlation with FISH.
Gerami P; Barnhill RL; Beilfuss BA; LeBoit P; Schneider P; Guitart J
Am J Surg Pathol; 2010 Jun; 34(6):816-21. PubMed ID: 20431478
[TBL] [Abstract][Full Text] [Related]
24. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms.
Lang UE; Torres R; Cheung C; Vladar EK; McCalmont TH; Kim J; Judson-Torres RL
J Invest Dermatol; 2020 Jul; 140(7):1401-1409.e2. PubMed ID: 31978411
[TBL] [Abstract][Full Text] [Related]
25. Targeted next generation sequencing (NGS) to classify melanocytic neoplasms.
Zarabi SK; Azzato EM; Tu ZJ; Ni Y; Billings SD; Arbesman J; Funchain P; Gastman B; Farkas DH; Ko JS
J Cutan Pathol; 2020 Aug; 47(8):691-704. PubMed ID: 32291779
[TBL] [Abstract][Full Text] [Related]
26. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions.
Minca EC; Al-Rohil RN; Wang M; Harms PW; Ko JS; Collie AM; Kovalyshyn I; Prieto VG; Tetzlaff MT; Billings SD; Andea AA
Mod Pathol; 2016 Aug; 29(8):832-43. PubMed ID: 27174586
[TBL] [Abstract][Full Text] [Related]
27. Concordance Analysis of the 23-Gene Expression Signature (myPath Melanoma) With Fluorescence In Situ Hybridization Assay and Single Nucleotide Polymorphism Array in the Analysis of Challenging Melanocytic Lesions: Results From an Academic Medical Center.
Castillo SA; Pham AK; Dagrosa AT; Yan S; Barton DT; Lefferts JA; Linos K
Am J Dermatopathol; 2020 Dec; 42(12):939-947. PubMed ID: 32675469
[TBL] [Abstract][Full Text] [Related]
28. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
Kerr KF; Elder DE; Piepkorn MW; Knezevich SR; Eguchi MM; Shucard HL; Reisch LM; Elmore JG; Barnhill RL
JAMA Dermatol; 2023 Dec; 159(12):1315-1322. PubMed ID: 37938821
[TBL] [Abstract][Full Text] [Related]
29. Lack of distinct molecular profile of Primary Dermal Melanoma.
Shaigany S; Tessier-Cloutier B; Busam KJ; Horst BA
Hum Pathol; 2020 Dec; 106():32-38. PubMed ID: 32946880
[TBL] [Abstract][Full Text] [Related]
30. Desmoplastic melanoma.
Busam KJ
Clin Lab Med; 2011 Jun; 31(2):321-30. PubMed ID: 21549245
[TBL] [Abstract][Full Text] [Related]
31. Molecular testing for melanocytic tumors: a practical update.
Andea AA
Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
[TBL] [Abstract][Full Text] [Related]
32. PRAME Expression Correlates With Genomic Aberration and Malignant Diagnosis of Spitzoid Melanocytic Neoplasms.
Gerami P; Benton S; Zhao J; Zhang B; Lampley N; Roth A; Boutko A; Olivares S; Busam KJ
Am J Dermatopathol; 2022 Aug; 44(8):575-580. PubMed ID: 35503885
[TBL] [Abstract][Full Text] [Related]
33. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.
Dinnes J; Deeks JJ; Chuchu N; Ferrante di Ruffano L; Matin RN; Thomson DR; Wong KY; Aldridge RB; Abbott R; Fawzy M; Bayliss SE; Grainge MJ; Takwoingi Y; Davenport C; Godfrey K; Walter FM; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011902. PubMed ID: 30521682
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.
Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL;
J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
[TBL] [Abstract][Full Text] [Related]
37. A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
Casillas AC; Muhlbauer A; Barragan VA; Jefferson I; Speiser JJ
Am J Dermatopathol; 2024 Mar; 46(3):137-146. PubMed ID: 38354382
[TBL] [Abstract][Full Text] [Related]
38. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.
Carlson JA; Caldeira Xavier JC; Tarasen A; Sheehan CE; Otto G; Miller VA; Stephens PJ; Elvin JA; Vergilio JA; Suh J; Gay LM; Ross JS
Am J Dermatopathol; 2017 Jan; 39(1):1-13. PubMed ID: 28045747
[TBL] [Abstract][Full Text] [Related]
39. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
40. Reliability and inter-observer agreement of dermoscopic diagnosis of melanoma and melanocytic naevi. Dermoscopy Panel.
Carli P; De Giorgi V; Naldi L; Dosi G
Eur J Cancer Prev; 1998 Oct; 7(5):397-402. PubMed ID: 9884886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
